Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.11
Peer-review started: September 1, 2016
First decision: September 20, 2016
Revised: October 14, 2016
Accepted: December 8, 2016
Article in press: December 8, 2016
Published online: January 7, 2017
Processing time: 129 Days and 17.7 Hours
Fecal incontinence is not a diagnosis but a frequent and debilitating common final pathway symptom resulting from numerous different causes. Incontinence not only impacts the patient’s self-esteem and quality of life but may result in significant secondary morbidity, disability, and cost. Treatment is difficult without any panacea and an individualized approach should be chosen that frequently combines different modalities. Several new technologies have been developed and their specific roles will have to be defined. The scope of this review is outline the evaluation and treatment of patients with fecal incontinence.
Core tip: Fecal incontinence is frequent, under-reported, and lacks a perfect treatment solution. Fecal control is not equivalent to normal sphincter muscles. Other factors such (e.g., stool consistency, rectal reservoir function and elasticity are equally important. Incontinence is rather a symptom than a diagnosis, representing the common final pathway of various etiologies. Measurement of fecal incontinence remains subjective and based on patient reporting. Successful incontinence management combines a thorough understanding of contributing factors, workup and interpretation of individual results, tailoring of individual treatment plan. New technologies are abundant but not indicated for all patients, and objective results often less strong than advertised.